Post-approval studies (Phase 4)Ended earlyNCT02887677
What this trial is testing
Effects of Dapagliflozin on Central Hemodynamics and Urine Albumin Excretion in Patients With Type 2 Diabetes.
Who this might be right for
Diabetes Mellitus
Hellenic Society for Medical Education 85